Global Genitourinary Drugs Market Professional Survey Report 2016

Publisher Name :
Date: 26-Sep-2016
No. of pages: 115
Inquire Before Buying

Notes:

Production, means the output of Genitourinary Drugs

Revenue, means the sales value of Genitourinary Drugs

This report studies Genitourinary Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

- Astellas

- Pfizer

- GlaxoSmithKline

- Eli Lilly

- Bayer AG

- Merck

- Abbott Laboratories

- Bristol-Myers Squibb

- Genentech

- Roche

- Amgen

- Botex

By types, the market can be split into

- Sex Hormones

- Urologicals

- Genitourinary Anti-Infectives

- Gynaecologicals

By Application, the market can be split into

- Genitourinary Cancer

- Bladder Cancer

- Cervical Cancer

- Kidney/Renal Cancer

- Ovarian Cancer

- Prostate Cancer

By Regions, this report covers (we can add the regions/countries as you want)

- North America

- China

- Europe

- Southeast Asia

- Japan

- India

Global Genitourinary Drugs Market Professional Survey Report 2016

Table of Contents
Global Genitourinary Drugs Market Professional Survey Report 2016
1 Industry Overview of Genitourinary Drugs
1.1 Definition and Specifications of Genitourinary Drugs
1.1.1 Definition of Genitourinary Drugs
1.1.2 Specifications of Genitourinary Drugs
1.2 Classification of Genitourinary Drugs
1.2.1 Sex Hormones
1.2.2 Urologicals
1.2.3 Genitourinary Anti-Infectives
1.2.4 Gynaecologicals
1.3 Applications of Genitourinary Drugs
1.3.1 Genitourinary Cancer
1.3.2 Bladder Cancer
1.3.3 Cervical Cancer
1.3.4 Kidney/Renal Cancer
1.3.5 Ovarian Cancer
1.3.6 Prostate Cancer
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
2 Manufacturing Cost Structure Analysis of Genitourinary Drugs
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Genitourinary Drugs
2.3 Manufacturing Process Analysis of Genitourinary Drugs
2.4 Industry Chain Structure of Genitourinary Drugs
3 Technical Data and Manufacturing Plants Analysis of Genitourinary Drugs
3.1 Capacity and Commercial Production Date of Global Genitourinary Drugs Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Genitourinary Drugs Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Genitourinary Drugs Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Genitourinary Drugs Major Manufacturers in 2015
4 Global Genitourinary Drugs Overall Market Overview
4.1 2011-2016E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2011-2016E Global Genitourinary Drugs Capacity and Growth Rate Analysis
4.2.2 2015 Genitourinary Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2016E Global Genitourinary Drugs Sales and Growth Rate Analysis
4.3.2 2015 Genitourinary Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2016E Global Genitourinary Drugs Sales Price
4.4.2 2015 Genitourinary Drugs Sales Price Analysis (Company Segment)
5 Genitourinary Drugs Regional Market Analysis
5.1 North America Genitourinary Drugs Market Analysis
5.1.1 North America Genitourinary Drugs Market Overview
5.1.2 North America 2011-2016E Genitourinary Drugs Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2011-2016E Genitourinary Drugs Sales Price Analysis
5.1.4 North America 2015 Genitourinary Drugs Market Share Analysis
5.2 China Genitourinary Drugs Market Analysis
5.2.1 China Genitourinary Drugs Market Overview
5.2.2 China 2011-2016E Genitourinary Drugs Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2011-2016E Genitourinary Drugs Sales Price Analysis
5.2.4 China 2015 Genitourinary Drugs Market Share Analysis
5.3 Europe Genitourinary Drugs Market Analysis
5.3.1 Europe Genitourinary Drugs Market Overview
5.3.2 Europe 2011-2016E Genitourinary Drugs Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2011-2016E Genitourinary Drugs Sales Price Analysis
5.3.4 Europe 2015 Genitourinary Drugs Market Share Analysis
5.4 Southeast Asia Genitourinary Drugs Market Analysis
5.4.1 Southeast Asia Genitourinary Drugs Market Overview
5.4.2 Southeast Asia 2011-2016E Genitourinary Drugs Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2011-2016E Genitourinary Drugs Sales Price Analysis
5.4.4 Southeast Asia 2015 Genitourinary Drugs Market Share Analysis
5.5 Japan Genitourinary Drugs Market Analysis
5.5.1 Japan Genitourinary Drugs Market Overview
5.5.2 Japan 2011-2016E Genitourinary Drugs Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2011-2016E Genitourinary Drugs Sales Price Analysis
5.5.4 Japan 2015 Genitourinary Drugs Market Share Analysis
5.6 India Genitourinary Drugs Market Analysis
5.6.1 India Genitourinary Drugs Market Overview
5.6.2 India 2011-2016E Genitourinary Drugs Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2011-2016E Genitourinary Drugs Sales Price Analysis
5.6.4 India 2015 Genitourinary Drugs Market Share Analysis
6 Global 2011-2016E Genitourinary Drugs Segment Market Analysis (by Type)
6.1 Global 2011-2016E Genitourinary Drugs Sales by Type
6.2 Different Types of Genitourinary Drugs Product Interview Price Analysis
6.3 Different Types of Genitourinary Drugs Product Driving Factors Analysis
6.3.1 Sex Hormones of Genitourinary Drugs Growth Driving Factor Analysis
6.3.2 Urologicals of Genitourinary Drugs Growth Driving Factor Analysis
6.3.3 Genitourinary Anti-Infectives of Genitourinary Drugs Growth Driving Factor Analysis
6.3.4 Gynaecologicals of Genitourinary Drugs Growth Driving Factor Analysis
7 Global 2011-2016E Genitourinary Drugs Segment Market Analysis (by Application)
7.1 Global 2011-2016E Genitourinary Drugs Consumption by Application
7.2 Different Application of Genitourinary Drugs Product Interview Price Analysis
7.3 Different Application of Genitourinary Drugs Product Driving Factors Analysis
7.3.1 Genitourinary Cancer of Genitourinary Drugs Growth Driving Factor Analysis
7.3.2 Bladder Cancer of Genitourinary Drugs Growth Driving Factor Analysis
7.3.3 Cervical Cancer of Genitourinary Drugs Growth Driving Factor Analysis
7.3.4 Kidney/Renal Cancer of Genitourinary Drugs Growth Driving Factor Analysis
7.3.5 Ovarian Cancer of Genitourinary Drugs Growth Driving Factor Analysis
7.3.6 Prostate Cancer of Genitourinary Drugs Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Genitourinary Drugs
8.1 Astellas
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Type I
8.1.2.2 Type II
8.1.2.3 Type III
8.1.3 Astellas 2015 Genitourinary Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Astellas 2015 Genitourinary Drugs Business Region Distribution Analysis
8.2 Pfizer
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Type I
8.2.2.2 Type II
8.2.2.3 Type III
8.2.3 Pfizer 2015 Genitourinary Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Pfizer 2015 Genitourinary Drugs Business Region Distribution Analysis
8.3 GlaxoSmithKline
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Type I
8.3.2.2 Type II
8.3.2.3 Type III
8.3.3 GlaxoSmithKline 2015 Genitourinary Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 GlaxoSmithKline 2015 Genitourinary Drugs Business Region Distribution Analysis
8.4 Eli Lilly
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Type I
8.4.2.2 Type II
8.4.2.3 Type III
8.4.3 Eli Lilly 2015 Genitourinary Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Eli Lilly 2015 Genitourinary Drugs Business Region Distribution Analysis
8.5 Bayer AG
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Type I
8.5.2.2 Type II
8.5.2.3 Type III
8.5.3 Bayer AG 2015 Genitourinary Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Bayer AG 2015 Genitourinary Drugs Business Region Distribution Analysis
8.6 Merck
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Type I
8.6.2.2 Type II
8.6.2.3 Type III
8.6.3 Merck 2015 Genitourinary Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Merck 2015 Genitourinary Drugs Business Region Distribution Analysis
8.7 Abbott Laboratories
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Type I
8.7.2.2 Type II
8.7.2.3 Type III
8.7.3 Abbott Laboratories 2015 Genitourinary Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Abbott Laboratories 2015 Genitourinary Drugs Business Region Distribution Analysis
8.8 Bristol-Myers Squibb
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Type I
8.8.2.2 Type II
8.8.2.3 Type III
8.8.3 Bristol-Myers Squibb 2015 Genitourinary Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Bristol-Myers Squibb 2015 Genitourinary Drugs Business Region Distribution Analysis
8.9 Genentech
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Type I
8.9.2.2 Type II
8.9.2.3 Type III
8.9.3 Genentech 2015 Genitourinary Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Genentech 2015 Genitourinary Drugs Business Region Distribution Analysis
8.10 Roche
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Type I
8.10.2.2 Type II
8.10.2.3 Type III
8.10.3 Roche 2015 Genitourinary Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Roche 2015 Genitourinary Drugs Business Region Distribution Analysis
8.11 Amgen
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.2.1 Type I
8.11.2.2 Type II
8.11.2.3 Type III
8.11.3 Amgen 2015 Genitourinary Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 Amgen 2015 Genitourinary Drugs Business Region Distribution Analysis
8.12 Botex
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.2.1 Type I
8.12.2.2 Type II
8.12.2.3 Type III
8.12.3 Botex 2015 Genitourinary Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 Botex 2015 Genitourinary Drugs Business Region Distribution Analysis
9 Development Trend of Analysis of Genitourinary Drugs Market
9.1 Global Genitourinary Drugs Market Trend Analysis
9.1.1 Global 2016-2021 Genitourinary Drugs Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Genitourinary Drugs Sales Price Forecast
9.2 Genitourinary Drugs Regional Market Trend
9.2.1 North America 2016-2021 Genitourinary Drugs Consumption Forecast
9.2.2 China 2016-2021 Genitourinary Drugs Consumption Forecast
9.2.3 Europe 2016-2021 Genitourinary Drugs Consumption Forecast
9.2.4 Southeast Asia 2016-2021 Genitourinary Drugs Consumption Forecast
9.2.5 Japan 2016-2021 Genitourinary Drugs Consumption Forecast
9.2.6 India 2016-2021 Genitourinary Drugs Consumption Forecast
9.3 Genitourinary Drugs Market Trend (Product Type)
9.4 Genitourinary Drugs Market Trend (Application)
10 Genitourinary Drugs Marketing Type Analysis
10.1 Genitourinary Drugs Regional Marketing Type Analysis
10.2 Genitourinary Drugs International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Genitourinary Drugs by Regions
10.4 Genitourinary Drugs Supply Chain Analysis
11 Consumers Analysis of Genitourinary Drugs
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 Conclusion of the Global Genitourinary Drugs Market Professional Survey Report 2016
Author List
Table Part of Interviewees Record List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
List of Tables and Figures
Figure Picture of Genitourinary Drugs
Table Product Specifications of Genitourinary Drugs
Table Classification of Genitourinary Drugs
Figure Global Production Market Share of Genitourinary Drugs by Type in 2015
Figure Sex Hormones Picture
Table Major Manufacturers of Sex Hormones
Figure Urologicals Picture
Table Major Manufacturers of Urologicals
Figure Genitourinary Anti-Infectives Picture
Table Major Manufacturers of Genitourinary Anti-Infectives
Figure Gynaecologicals Picture
Table Major Manufacturers of Gynaecologicals
Table Applications of Genitourinary Drugs
Figure Global Consumption Volume Market Share of Genitourinary Drugs by Application in 2015
Figure Genitourinary Cancer Examples
Table Major Consumers of Genitourinary Cancer
Figure Bladder Cancer Examples
Table Major Consumers of Bladder Cancer
Figure Cervical Cancer Examples
Table Major Consumers of Cervical Cancer
Figure Kidney/Renal Cancer Examples
Table Major Consumers of Kidney/Renal Cancer
Figure Ovarian Cancer Examples
Table Major Consumers of Ovarian Cancer
Figure Prostate Cancer Examples
Table Major Consumers of Prostate Cancer
Figure Market Share of Genitourinary Drugs by Regions
Figure North America Genitourinary Drugs Market Size (2011-2021)
Figure China Genitourinary Drugs Market Size (2011-2021)
Figure Europe Genitourinary Drugs Market Size (2011-2021)
Figure Southeast Asia Genitourinary Drugs Market Size (2011-2021)
Figure Japan Genitourinary Drugs Market Size (2011-2021)
Figure India Genitourinary Drugs Market Size (2011-2021)
Table Genitourinary Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Genitourinary Drugs in 2015
Figure Manufacturing Process Analysis of Genitourinary Drugs
Figure Industry Chain Structure of Genitourinary Drugs
Table Capacity (Unit) and Commercial Production Date of Global Genitourinary Drugs Major Manufacturers in 2015
Table Manufacturing Plants Distribution of Global Genitourinary Drugs Major Manufacturers in 2015
Table R&D Status and Technology Source of Global Genitourinary Drugs Major Manufacturers in 2015
Table Raw Materials Sources Analysis of Global Genitourinary Drugs Major Manufacturers in 2015
Table Global Capacity (Unit), Sales (Unit), Price (USD/Unit), Cost (USD/Unit), Sales Revenue (M USD) and Gross Margin of Genitourinary Drugs 2011-2016
Figure Global 2011-2016E Genitourinary Drugs Market Size (Volume) and Growth Rate
Figure Global 2011-2016E Genitourinary Drugs Market Size (Value) and Growth Rate
Table 2011-2016E Global Genitourinary Drugs Capacity and Growth Rate
Table 2015 Global Genitourinary Drugs Capacity List (Company Segment)
Table 2011-2016E Global Genitourinary Drugs Sales and Growth Rate
Table 2015 Global Genitourinary Drugs Sales List (Company Segment)
Table 2011-2016E Global Genitourinary Drugs Sales Price
Table 2015 Global Genitourinary Drugs Sales Price List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption of Genitourinary Drugs 2011-2016 (Unit)
Figure North America 2011-2016E Genitourinary Drugs Sales Price (USD/Unit)
Figure North America 2015 Genitourinary Drugs Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption of Genitourinary Drugs 2011-2016 (Unit)
Figure China 2011-2016E Genitourinary Drugs Sales Price (USD/Unit)
Figure China 2015 Genitourinary Drugs Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption of Genitourinary Drugs 2011-2016 (Unit)
Figure Europe 2011-2016E Genitourinary Drugs Sales Price (USD/Unit)
Figure Europe 2015 Genitourinary Drugs Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption of Genitourinary Drugs 2011-2016 (Unit)
Figure Southeast Asia 2011-2016E Genitourinary Drugs Sales Price (USD/Unit)
Figure Southeast Asia 2015 Genitourinary Drugs Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption of Genitourinary Drugs 2011-2016 (Unit)
Figure Japan 2011-2016E Genitourinary Drugs Sales Price (USD/Unit)
Figure Japan 2015 Genitourinary Drugs Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption of Genitourinary Drugs 2011-2016 (Unit)
Figure India 2011-2016E Genitourinary Drugs Sales Price (USD/Unit)
Figure India 2015 Genitourinary Drugs Sales Market Share
Table Global 2011-2016E Genitourinary Drugs Sales by Type
Table Different Types Genitourinary Drugs Product Interview Price
Table Global 2011-2016E Genitourinary Drugs Sales by Application
Table Different Application Genitourinary Drugs Product Interview Price
Table Astellas Information List
Table Type I Genitourinary Drugs Overview
Table Type II Genitourinary Drugs Overview
Table Type III Genitourinary Drugs Overview
Table 2015 Astellas Genitourinary Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Astellas 2015 Genitourinary Drugs Business Region Distribution
Table Pfizer Information List
Table Type I Genitourinary Drugs Overview
Table Type II Genitourinary Drugs Overview
Table Type III Genitourinary Drugs Overview
Table 2015 Pfizer Genitourinary Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Pfizer 2015 Genitourinary Drugs Business Region Distribution
Table GlaxoSmithKline Information List
Table Type I Genitourinary Drugs Overview
Table Type II Genitourinary Drugs Overview
Table Type III Genitourinary Drugs Overview
Table 2015 GlaxoSmithKline Genitourinary Drugs Revenue, Sales, Ex-factory Price
Figure 2015 GlaxoSmithKline 2015 Genitourinary Drugs Business Region Distribution
Table Eli Lilly Information List
Table Type I Genitourinary Drugs Overview
Table Type II Genitourinary Drugs Overview
Table Type III Genitourinary Drugs Overview
Table 2015 Eli Lilly Genitourinary Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Eli Lilly 2015 Genitourinary Drugs Business Region Distribution
Table Bayer AG Information List
Table Type I Genitourinary Drugs Overview
Table Type II Genitourinary Drugs Overview
Table Type III Genitourinary Drugs Overview
Table 2015 Bayer AG Genitourinary Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Bayer AG 2015 Genitourinary Drugs Business Region Distribution
Table Merck Information List
Table Type I Genitourinary Drugs Overview
Table Type II Genitourinary Drugs Overview
Table Type III Genitourinary Drugs Overview
Table 2015 Merck Genitourinary Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Merck 2015 Genitourinary Drugs Business Region Distribution
Table Abbott Laboratories Information List
Table Type I Genitourinary Drugs Overview
Table Type II Genitourinary Drugs Overview
Table Type III Genitourinary Drugs Overview
Table 2015 Abbott Laboratories Genitourinary Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Abbott Laboratories 2015 Genitourinary Drugs Business Region Distribution
Table Bristol-Myers Squibb Information List
Table Type I Genitourinary Drugs Overview
Table Type II Genitourinary Drugs Overview
Table Type III Genitourinary Drugs Overview
Table 2015 Bristol-Myers Squibb Genitourinary Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Bristol-Myers Squibb 2015 Genitourinary Drugs Business Region Distribution
Table Genentech Information List
Table Type I Genitourinary Drugs Overview
Table Type II Genitourinary Drugs Overview
Table Type III Genitourinary Drugs Overview
Table 2015 Genentech Genitourinary Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Genentech 2015 Genitourinary Drugs Business Region Distribution
Table Roche Information List
Table Type I Genitourinary Drugs Overview
Table Type II Genitourinary Drugs Overview
Table Type III Genitourinary Drugs Overview
Table 2015 Roche Genitourinary Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Roche 2015 Genitourinary Drugs Business Region Distribution
Table Amgen Information List
Table Type I Genitourinary Drugs Overview
Table Type II Genitourinary Drugs Overview
Table Type III Genitourinary Drugs Overview
Table 2015 Amgen Genitourinary Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Amgen 2015 Genitourinary Drugs Business Region Distribution
Table Botex Information List
Table Type I Genitourinary Drugs Overview
Table Type II Genitourinary Drugs Overview
Table Type III Genitourinary Drugs Overview
Table 2015 Botex Genitourinary Drugs Revenue, Sales, Ex-factory Price
Figure 2015 Botex 2015 Genitourinary Drugs Business Region Distribution
Figure Global 2016-2021 Genitourinary Drugs Market Size (Volume) and Growth Rate Forecast
Figure Global 2016-2021 Genitourinary Drugs Market Size (Value) and Growth Rate Forecast
Figure Global 2016-2021 Genitourinary Drugs Sales Price (USD/Unit) Forecast
Figure North America 2016-2021 Genitourinary Drugs Consumption Volume and Growth Rate Forecast
Figure China 2016-2021 Genitourinary Drugs Consumption Volume and Growth Rate Forecast
Figure Europe 2016-2021 Genitourinary Drugs Consumption Volume and Growth Rate Forecast
Figure Southeast Asia 2016-2021 Genitourinary Drugs Consumption Volume and Growth Rate Forecast
Figure Japan 2016-2021 Genitourinary Drugs Consumption Volume and Growth Rate Forecast
Figure India 2016-2021 Genitourinary Drugs Consumption Volume and Growth Rate Forecast
Table Global Sales Volume (Unit) of Genitourinary Drugs by Types 2016-2021
Table Global Consumption Volume (Unit) of Genitourinary Drugs by Applications 2016-2021
Table Traders or Distributors with Contact Information of Genitourinary Drugs by Regions
Table Part of Interviewees Record List
  • Global Bacillus Subtilis Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 24-Mar-2017        Price: US 3480 Onwards        Pages: 117
    Bacillus subtilis, known also as the hay bacillus or grass bacillus, is a Gram-positive, catalase-positive bacterium, found in soil and the gastrointestinal tract of ruminants and humans. A member of the genus Bacillus, B. subtilis is rod-shaped, and can form a tough, protective endospore, allowing it to tolerate extreme environmental conditions. B. subtilis has historically been classified as an obligate aerobe, though evidence exists that it is a facultative aerobe. B. subtilis is considered t......
  • Asia-Pacific Plasminogen Activator Inhibitor Market Report 2017
    Published: 23-Mar-2017        Price: US 4000 Onwards        Pages: 101
    In this report, the Asia-Pacific Plasminogen Activator Inhibitor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (volume), revenue (value), market share and growth rate of Plasminogen Activator Inhibitor for these regions, from 2012 to 2022 (forecast), including - China - Japan......
  • Asia-Pacific Natriuretic Peptide Market Report 2017
    Published: 23-Mar-2017        Price: US 4000 Onwards        Pages: 105
    In this report, the Asia-Pacific Natriuretic Peptide market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (volume), revenue (value), market share and growth rate of Natriuretic Peptide for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea -......
  • Asia-Pacific Demineralized Bone Matrix Market Report 2017
    Published: 23-Mar-2017        Price: US 4000 Onwards        Pages: 104
    In this report, the Asia-Pacific Demineralized Bone Matrix market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (volume), revenue (value), market share and growth rate of Demineralized Bone Matrix for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Ko......
  • Asia-Pacific Creatine Kinase Market Report 2017
    Published: 23-Mar-2017        Price: US 4000 Onwards        Pages: 104
    In this report, the Asia-Pacific Creatine Kinase market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (volume), revenue (value), market share and growth rate of Creatine Kinase for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Taiwan......
  • Asia-Pacific Cardiac Troponin Market Report 2017
    Published: 23-Mar-2017        Price: US 4000 Onwards        Pages: 105
    In this report, the Asia-Pacific Cardiac Troponin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (volume), revenue (value), market share and growth rate of Cardiac Troponin for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Taiwa......
  • Asia-Pacific Argatroban Market Report 2017
    Published: 23-Mar-2017        Price: US 4000 Onwards        Pages: 102
    In this report, the Asia-Pacific Argatroban market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (volume), revenue (value), market share and growth rate of Argatroban for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Taiwan - I......
  • EMEA (Europe, Middle East and Africa) Herbal Oil Market Report 2017
    Published: 23-Mar-2017        Price: US 4000 Onwards        Pages: 115
    In this report, the EMEA Herbal Oil market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Herbal Oil for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux; - Middle East......
  • United States Veterinary Pain Management Drugs Market Report 2017
    Published: 23-Mar-2017        Price: US 3800 Onwards        Pages: 105
    In this report, the United States Veterinary Pain Management Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share an......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs